Gurutz Linazasoro, CEO of VIVEbiotech, participates at Transfiere
Gurutz Linazasoro, CEO of VIVEbiotech and coordinator of the AseBio´s, the Spanish Bioindustry Association ´s, advanced therapies working group, participated yesterday in a round table at Transfiere, the European Forum for Science, Technology and Innovation.
Transfiere is said to be “the main R&D meeting in Southern Europe to share scientific and technological knowledge, promote innovation and connect science and business” and is being held at the FYCMA convention center in Málaga these days.
The round table entitled “Biotechnology in Cutting-Edge Health” sponsored by AseBio, had as objective “to value the work of the biotechnology sector in key areas such as advanced therapies, personalized medicine, drug discovery, resistance to antibiotics and access to innovation, to promote cutting-edge health and thus strengthen our health system”.
Many thanks to AseBio for this exceptional invitation, and to Gurutz for uniting the terms “biotechnology” and “cutting-edge health” so well, using VIVEbiotech as an example.